Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - CASH FROM OPERATIONS
Cash from Operations OCX - OncoCyte Corporation
-23.3 M
LAST VALUE
19.44%
2 YEAR CAGR
-14.90%
5 YEAR CAGR
-41.79%
10 YEAR CAGR